[1]李 婧,程涵芬.妊娠糖尿病患者尿液8-oxo-Gsn 表达水平及其对妊娠结局预测价值研究[J].现代检验医学杂志,2023,38(01):135-139.[doi:10.3969/j.issn.1671-7414.2023.01.025]
　LI Jing,CHENG Han-fen.Urinary 8-oxo-Gsn Expression Level in Patients with Gestational Diabetes Mellitus and Its Predictive Value for Pregnancy Outcome[J].Journal of Modern Laboratory Medicine,2023,38(01):135-139.[doi:10.3969/j.issn.1671-7414.2023.01.025]
点击复制

妊娠糖尿病患者尿液8-oxo-Gsn 表达水平及其对妊娠结局预测价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年01期
页码:
135-139
栏目:
论著
出版日期:
2023-01-15

文章信息/Info

Title:
Urinary 8-oxo-Gsn Expression Level in Patients with Gestational Diabetes Mellitus and Its Predictive Value for Pregnancy Outcome
文章编号:
1671-7414（2023）01-135-05
作者:
李 婧; 程涵芬
（汉川市中医医院检验科，湖北汉川 431600）
Author(s):
LI Jing;  CHENG Han-fen
fen（Department of Clinical Laboratory, Hanchuan Hospital of Traditional Chinese Medicine， Hubei Hanchuan 431600, China）
关键词:
8G- 氧化鸟苷; 妊娠糖尿病; 妊娠结局
分类号:
R714.256；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.01.025
文献标志码:
A
摘要:
目的 探讨妊娠糖尿病（gestational diabetes mellitus，GDM）患者尿液RNA 氧化标志物8G- 氧化鸟苷（8-oxo-7,8-dihydroguanosine，8-oxo-Gsn）的水平及与妊娠结局的关系。方法 选取2018 年2 月～ 2021 年2 月汉川市中医医院收治的106 例GDM 患者为观察组，根据妊娠结局情况分为妊娠结局良好组和妊娠结局不良组。另选取同期进行体检的90 例健康孕妇为对照组。收集所有孕妇的临床资料并进行比较。采用同位素稀释高效液相- 串联质谱法（isotopedilution high performance liquid phase-tandem mass spectrometry，ID-LC-MS/MS）分析尿液中8-oxo-Gsn 水平。采用ROC曲线评估8-oxo-Gsn 对GDM 患者不良妊娠结局的评估价值。多因素回归分析影响GDM 患者不良妊娠结局的危险因素。结果 与对照组相比，观察组尿液8-oxo-Gsn 水平（3.89±0.63 μmol/mol vs 2.26±0.47 μmol/mol）及不良妊娠结局的发生率（29.25% vs 11.11%）明显升高，差异有统计学意义（t=20.225，χ2=9.676，均P ＜ 0.05）。与妊娠结局良好组相比，妊娠结局不良组患者尿液8-oxo-Gsn 水平（4.67±0.77 μmol/mol vs 3.56±0.57μmol/mol）升高，差异有统计学意义（t=8.197，P ＜ 0.05）。ROC 曲线分析结果显示，8-oxo-Gsn 预测GDM 患者不良妊娠结局的曲线下面积为0.847，截断值为4.049 μmol/mol，敏感度和特异度分别为77.40%，81.30%。HOMA-IR[OR（95%CI）：4.726（2.027 ～ 11.021）]，8-oxo-Gsn[OR（95%CI）：5.591（2.239 ～ 13.964）] 是GDM 患者发生不良妊娠结局的独立危险因素（均P ＜ 0.05）。结论 GDM 患者尿液8-oxo-Gsn 水平升高，与患者不良妊娠结局有关，且对不良妊娠结局具有较优的预测价值。
Abstract:
Objective To investigate the level of urine RNA oxidation marker 8-oxo-7 and 8-dihydroguanosine (8-oxo-Gsn) in patients with gestational diabetes (GDM), and its relationship with pregnancy outcome. Methods A total of 106 GDM patients admitted to Hanchuan Hospital of Traditional Chinese Medicine from February 2018 to February 2021 were selected as the observation group, and divided into good pregnancy outcome group and bad pregnancy outcome group according to the pregnancy outcome. Another 90 healthy pregnant women who underwent physical examination during the same period were selected as the control group. The clinical data of all pregnant women were collected and compared. The level of 8-oxo-Gsn in urine of all pregnant women was analyzed by isotope dilution high performance liquid phase-tandem mass spectrometry (ID-LCMS/ MS). ROC curve was used to analyze the evaluation value of 8-oxo-Gsn for adverse pregnancy outcomes in GDM patients. Multivariate regression analysis affected risk factors for adverse pregnancy outcomes in GDM patients. Results Compared with the control group, the urine 8-oxo-Gsn level (3.89±0.63 μmol/mol vs 2.26±0.47 μmol/mol) and the incidence of adverse pregnancy outcomes (29.25% vs 11.11%) in the observation group were increased, and the differences were statistically significant (t=20.225, χ2=9.676, all P < 0.05). Compared with the good pregnancy outcome group, the urine 8-oxo-Gsn level (4.67±0.77 μmol/mol vs 3.56±0.57 μmol/mol) of pregnant women in the poor pregnancy outcome group was higher, and the difference was statistically significant (t=8.197, P<0.05). ROC curve analysis results showed that 8-oxo-Gsn predicted the area under the curve of pregnancy outcome in GDM patients was 0.847, the cut-off value was 4.049 μmol/mol, the sensitivity and the specificity were 77.40%, 81.30%，respectively. HOMA-IR [OR (95% CI): 4.726 (2.027 ～ 11.021)], 8-oxo-Gsn [OR (95% CI): 5.591 (2.239 ～ 13.964)] were independent risk factors for adverse pregnancy outcomes in GDM patients (all P<0.05). Conclusion Increased urine 8-oxo-Gsn level in GDM patients was associated with adverse pregnancy outcomes and has a better predictive value for adverse pregnancy outcomes.

参考文献/References:

[1] 许航, 贺丹, 罗晴. 育龄妇女年龄、孕前BMI 和孕早期空腹血糖水平分布在妊娠期糖尿病预测中的价值[J]. 现代检验医学杂志, 2021, 36(5):169-173.
XU Hang, HE Dan, LUO Qing. Value of age，prepregnancy body mass index and fasting blood glucose in early pregnancy in predicting gestational diabetes mellitus among fertile women [J]. Journal of Modern Laboratory Medicine, 2021, 36(5):169-173.
[2] GUALDANI E, DI CIANNI G, SEGHIERI M, et al.Pregnancy outcomes and maternal characteristics in women with pregestational and gestational diabetes: a retrospective study on 206 917 singleton live births[J].[J]. Acta Diabetologica, 2021, 58(9):1169-1176.
[3] CHEN Tong, LIU Dan. The mystery of exosomes in gestational diabetes mellitus [J]. Oxidative Medicine and Cellular Longevity, 2022, 2022: 2169259.
[4] ZHANG Bo , YANG Yang , YI Jianru , et al.Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis[J].Journal of Periodontal Research, 2021, 56(5):991-1005.
[5] 柳梅, 任维鑫, 郇娟, 等. 重症肝病合并真菌感染尿RNA 氧化产物8- 氧化鸟苷水平及临床意义[J]. 中华医院感染学杂志, 2021, 31(13):1952-1956.
LIU Mei, REN Weixin, HUAN Juan, et al. RNA oxidation product 8-oxidated guanosine in urine of severe liver disease patients complicated with nosocomial fungal infection and its clinical significance[J]. Chinese Journal of Nosocomiology, 2021,31(13):1952-1956.
[6] GAN Wei, LIU Xinle, YU Ting, et al. Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of aging[J]. Front Aging Neurosci, 2018, 10:34.
[7] LIANG Yaodan, LIU Qian, DU Minghui, et al. Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of frailty for elderly patients with cardiovascular disease[J]. Free Radic Biol Med, 2020, 152:248-254.
[8] 杨丽霞, 张厚亮, 吴洪章. 尿液8-oxo-Gsn 与丙型肝炎病毒感染引起肝损害的关系研究[J]. 国际检验医学杂志, 2020, 41(5):607-610.
YANG Lixia, ZHANG Houliang, WU Hongzhang. The relationship between urine 8-oxo-Gsn and hepatic damagecaused by hepatitis C virus infection [J].International Journal of Laboratory Medicine, 2020,41(5):607-610.
[9] 谢锦桃, 刘军, 伍远征, 等. 2011 年美国糖尿病协会糖尿病诊疗标准执行纲要解读[J]. 中国全科医学,2011, 14(18):1993-1997.
XIE Jintao, LIU Jun, WU Yuanzheng, et al. Interpreting the American Diabetes Associatiion(ADA) criteria for diagnosis and management of diabetes(2011) [J].Chinese General Practice, 2011, 14(18):1993-1997.
[10] 管小念, 尹霭琦, 童嘉宁, 等. 妊娠期糖尿病患者孕中期糖代谢指标与妊娠结局的关系[J]. 中国实用妇科与产科杂志, 2022, 38(5):553-557.
GUAN Xiaonian, YIN Aiqi, TONG Jianing, et al.Association between glucose metabolism indices in midpregnancy and pregnancy outcomes in women with gestational diabetes mellitus [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2022, 38(5):553-557.
[11] 邓任堂, 许红丽, 孔桂兴, 等. 液相芯片技术快速检测2 型糖尿病患者相关降糖药物基因多态性的方法学建立[J]. 现代检验医学杂志, 2021, 36(2):6-10,14.
DENG Rentang, XU Hongli, KONG Guixing, et al. Development of a liquid phase chip technology for simultaneous and rapid detecting of the gene polymorphisms in medications with type 2 diabetes mellitus [J]. Journal of Modern Laboratory Medicine,2021, 36(2):6-10,14.
[12] 孙奇林, 鞠婧, 王浩, 等. 黄芪多糖干预糖尿病心肌氧化应激的实验研究[J]. 中国中西医结合杂志,2020, 40(2):196-203.
SUN Qilin, JU Jing, WANG Hao, et al. Eeffect of astragalus polysaccharides in inhibiting myocardial oxidative stress of diabetes mellitus [J]. Chinese Journal of Integrated Traditional and Western Medicine, 2020,40(2):196-203.
[13] 练淑平, 张耀, 王振花. 氧化应激在糖尿病性心血管疾病中的研究进展[J]. 医学综述, 2019, 25(10):2029-2033.
LIAN Shuping, ZHANG Yao, WANG Zhenhua. Research progress of oxidative stress in diabetic cardiovascular disease [J]. Medical Recapitulate, 2019,25(10):2029-2033.
[14] JADHAV A, KHAIRE A, JOSHI S. Exploring the role of oxidative stress, fatty acids and neurotrophins in gestational diabetes mellitus[J].Growth Factors, 2020,38(3/4):226-234.
[15] EGUCHI N , VAZIRI N D , DAFOE D C , et al. The role of oxidative stress in pancreatic β cell dysfunction in diabetes.[J]. International Journal of Molecular Sciences, 2021, 22(4):1509.
[16] ZHANG Ruiping, YU Songlin, WANG Danchen,et al. Short-term biological variation and reference change values of urinary 8-oxo-7,8-dihydro-2’-deoxyguanosine and 8-oxo-7,8-dihydroguanosine[J]. Journal of Clinical Laboratory Analysis, 2020,34(12):e23522.
[17] 徐冷楠, 赵班, 王海涛, 等. 8- 氧化鸟苷对慢性肾脏病患者肾功能的评估价值[J]. 中华医学杂志, 2018,98 (42): 3415-3419.
XU Lengnan, ZHAO Ban, WANG Haitao, et al. Value of RNA oxidation product 8-oxo-Gsn in evaluating renal function in patients with chronic kidney disease [J]. National Medical Journal of China, 2018,98(42):3415-3419.
[18] 徐新民, 翁卿华, 郭杰, 等. 尿液8-oxo-Gsn 和8-oxo-dGsn 对HBV 感染引起肝损伤程度的价值评估 [J]. 医学研究杂志, 2018, 47(2):74-78.
XU Xinmin, WENG Qinghua, GUO Jie, et al.Evaluation of urinary 8-oxo-Gsn and 8-oxo-dGsn for the extent of liver damage caused by HBV infection [J].Journal of Medical Research, 2018, 47(2):74-78.
[19] 张瑞苹, 禹松林, 王丹晨, 等. 原发性高血压患者体内DNA 和RNA 氧化产物8- 氧化鸟苷和8- 氧化脱氧鸟苷水平分析[J]. 中华检验医学杂志, 2020,43(3):274-278.
ZHANG Ruiping, YU Songlin, WANG Danchen, et al. Analysis of the oxidative products of DNA(8-oxo Gsn)and RNA(8-oxo dGsn)in patients with essential hypertension [J]. Chinese Journal of Laboratory Medicine, 2020, 43(3):274-278.
[20] BROEDBAEK K, K?STER-RASMUSSEN R,SIERSMA V, et al. Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes - A comparative study of two markers to identify high risk patients [J]. Redox Biology, 2017,13:363-369.
[21] MAO Yonghui, WENG Qinghua, XU Lengnan, et al.Levels of 8-oxo-dGsn and 8-oxo-Gsn in random urine are consistent with 24 h urine in healthy subjects and patients with renal disease [J]. Free Radical Research,2017, 51(6):616-621.
[22] 陆文茜, 于祥田, 罗明娟, 等. 妊娠期糖尿病不良妊娠结局的危险因素和代谢组学联合分析[J]. 中华糖尿病杂志, 2021, 13(6):578-583.
LU Wenqian, YU Xiangtian, LUO Mingjuan, et al.Combination analysis of risk factors and metabolomics on gestational diabetes mellitus with adverse pregnancy outcomes[J]. Chinese Journal of Diabetes, 2021,13(6):578-583.
[23] 沈琼, 高贝贝, 章茜, 等. 妊娠期糖尿病患者糖化白蛋白、内脂素、摄食抑制因子-1 水平与胰岛素抵抗和妊娠结局的关系分析[J]. 现代生物医学进展,2022, 22(6):1137-1141,1130.
SHEN Qiong, GAO Beibei, ZHANG Qian, et al.Relationship analysis between glycated albumin,visfatin and nesfatin-1 level and insulin resistance and pregnancy outcome in patients with gestational diabetes mellitus [J]. Progress in Modern Biomedicine, 2022,22(6):1137-1141,1130.

相似文献/References:

[1]陈　霏,王　碧.血清游离雌三醇和脂联素水平与妊娠糖尿病孕晚期发生胎儿窘迫的相关性研究[J].现代检验医学杂志,2019,34(06):101.[doi:10.3969 ／ j.issn.1671-7414.2019.06.025]
　CHEN Fei,WANG Bi.Correlation Research on Serum Levels of Free Estriol and Adiponectin in Fetal Distress in Late Pregnancy of Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2019,34(01):101.[doi:10.3969 ／ j.issn.1671-7414.2019.06.025]
[2]梁培松,王结珍,陈 康,等.孕早期年龄,BMI 和PAPPA 水平综合评价对GDM 的预测价值[J].现代检验医学杂志,2020,35(01):133.[doi:10.3969/j.issn.1671-7414.2020.01.035]
　LIANG Pei-song,WANG Jie-zhen,CHEN Kang,et al.Predictive Value of Comprehensive Evaluation of Early Pregnant Age,BMI and PAPPA Levels to the GDM[J].Journal of Modern Laboratory Medicine,2020,35(01):133.[doi:10.3969/j.issn.1671-7414.2020.01.035]
[3]梁玉珊a,朱冬梅b,尤芳芳a.妊娠期糖尿病患者血、尿生化指标与尿路结石发生的相关指标分析[J].现代检验医学杂志,2020,35(02):142.[doi:10.3969 ／ j.issn.1671-7414.2020.02.039]
　LIANG Yu-shana,ZHU Dong-meib,YOU Fang-fanga.Analysis of Correlation between Blood and Urine Biochemical Indexes andUrinary Calculus in Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(01):142.[doi:10.3969 ／ j.issn.1671-7414.2020.02.039]
[4]李　艳,李新宇.妊娠糖尿病患者外周血miRNA-21 检测的临床应用价值[J].现代检验医学杂志,2020,35(02):35.[doi:10.3969/j.issn.1671-7414.2020.02.011]
　LI Yan,LI Xin-yu.Clinical Application Value of Detection of miRNA-21 in Peripheral Blood ofPatients with Gestational Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(01):35.[doi:10.3969/j.issn.1671-7414.2020.02.011]
[5]陈丽华a,王思思b,朱婕曼a,等.高龄产妇孕中期血清 FPG，HbA1c 及 TC 联合检测预测 GDM 风险的临床研究[J].现代检验医学杂志,2020,35(06):33.[doi:doi:10.3969/j.issn.1671-7414.2020.06.009]
　CHEN Li-hua a,WANGg Si-si b,ZHU Jie-man a,et al.Clinical Study on Prediction of GDM Risk by Combined Detection of SerumFPG, HbA1c and TC in the Second Trimester of Pregnancy in Elderly Women[J].Journal of Modern Laboratory Medicine,2020,35(01):33.[doi:doi:10.3969/j.issn.1671-7414.2020.06.009]
[6]丁　洁,何晓一,刘彦君,等.妊娠糖尿病患者胎盘LPL基因Hind片段多态性与新生儿发生胰岛素抵抗风险的相关性研究[J].现代检验医学杂志,2021,36(06):70.[doi:10.3969/j.issn.1671-7414.2021.06.014]
　DING Jie,HE Xiao-yi,LIU Yan-jun,et al.Relevance between Hind Fragment Polymorphism of Placental LPL Gene and the Risk of Neonatal Insulin Resistance in Patients with Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2021,36(01):70.[doi:10.3969/j.issn.1671-7414.2021.06.014]
[7]王　伟,张　静,浦　春.妊娠糖尿病患者血清、脐血及胎盘组织中 Visfatin和 Chemerin的表达与胰岛素抵抗发生机制的研究[J].现代检验医学杂志,2022,37(01):21.[doi:10.3969/j.issn.1671-7414.2022.01.005]
　WANG Wei,ZHANG Jing,PU Chun.Expression of Visfatin and Chemerin in Serum, Umbilical Blood and Placenta of Patients with Gestational Diabetes Mellitus andthe Mechanism of Insulin Resistance[J].Journal of Modern Laboratory Medicine,2022,37(01):21.[doi:10.3969/j.issn.1671-7414.2022.01.005]

备注/Memo

备注/Memo:
作者简介：李婧（1987-），女，本科，主管技师，主要研究方向：临床检验，E-mail:li_doctor00@yeah.net。
通讯作者：程涵芬（1981-），E-mail：fly_777@yeah.net。
更新日期/Last Update: 2023-01-15